Gregory Alan Konesky insider trades: Bovie Medical (BVX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gregory reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 23, 2011 | BVX | ↓ Sell | 750 | $2.40 | $2K | Direct | Dec 29, 2011 (6d) |
| May 20, 2011 | BVX | ↓ Sell | 800 | $2.99 | $2K | Direct | May 24, 2011 (4d) |
| Sep 17, 2010 | BVX | ↓ Sell | 750 | $2.40 | $2K | Direct | Sep 23, 2010 (6d) |
| Mar 29, 2010 | BVX | ↓ Sell | 1,000 | $6.45 | $6K | Direct | Apr 1, 2010 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gregory Alan Konesky's insider trades
Gregory Alan Konesky is a director at Bovie Medical (BVX). Since Mar 29, 2010, Gregory has reported no open-market purchases and 4 sales worth $12K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.